What are the best strategies for preventing falls in people with MS based on specific causes, such as dizziness or weakness? Are combinations of some strategies more effective than single strategies alone?
Does the effectiveness of the COVID-19 vaccines differ based on duration of treatment with a B-cell depleting drug?
Do the COVID-19 vaccines have specific effects on people with MS that haven’t been observed with other types of vaccines? If so, what is responsible for these differences?
Should people with MS on B-cell depleting therapies be tested for antibodies after being fully vaccinated as part of standard clinical care?
Among patients who don't mount a high antibody response to vaccination, would an extra booster dose be helpful?
Could the COVID-19 vaccine trigger the onset of MS in those who are already at a higher risk of developing it, such as direct relatives of people diagnosed with MS?
Does the COVID-19 vaccine have the potential to help resolve residual neurological symptoms in people with MS, based on evidence of improvement in fatigue and cognitive issues seen in COVID long haulers?
